A Delphi Study on National Public Vaccine Research and Development Policy in Korea.
10.4332/KJHPA.2015.25.2.140
- Author:
Somin LEE
1
;
Sang Gu YEO
;
Shin Jung KANG
;
Soon Young HAN
;
Sang Won LEE
Author Information
1. Center for Infectious Diseases, National Institute of Health, Korea Centers for Disease Control and Prevention, Korea. epilsw@korea.kr
- Publication Type:Original Article
- Keywords:
Vaccine research and development;
Policy;
Delphi technique
- MeSH:
Communicable Diseases;
Delphi Technique*;
Immunization;
Korea*;
Mycobacterium bovis;
Public Health;
Tuberculosis;
Vaccination;
Vaccines
- From:Health Policy and Management
2015;25(2):140-148
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Vaccination is the most powerful and useful preparation against infectious diseases. However, developing vaccines costs a lot and requires extensive long-term efforts. Therefore, the government should research and develop vaccines with a national-level policy. To greatly enhance the success rate of vaccine development, the policy should be set up considering priorities such as the current status of domestic research, the importance for public health, the urgency of research. The Delphi technique was utilized to draft this survey, through a brainstorming stage, then two inquiries, and finally the final panel meeting where unresolved items were discussed, to draw the conclusion. Among the results, firstly, the highest ranked item on centralized fields for vaccine development by the Ministry of Health was 'self-sufficiency of vaccines.' Secondly, 'emerging infectious disease' was most highly ranked in prioritized fields of vaccine development and research. Thirdly, for the vaccine that needs to be improved and developed further by the government to improve its efficacy and safety, BCG (Bacille de Calmette) for tuberculosis was ranked the highest on both types (intradermal and subcutaneous injection) from National Immunization Programme (NIP) and non-NIP. As for the high risk pathogens, 'anthrax' and 'smallpox' were first and second, consecutively. Lastly, 'development and control of vaccine candidates' was ranked the highest for the area in need for technique development in order to improve domestic vaccine's research level. The results of this study will be put to good use as basic data for the national vaccine research and development (R&D) policy of the country. This study was first step and more studies should be carried out for the final decision of the national vaccine R&D priority.
